Case number 1:19-cv-00926
Vanda Pharmaceuticals Inc. v. MSN Pharmaceuticals Inc. et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Jan 19, 2022 | N/A | Terminated Case (0) Docket Text: CASES CLOSED per the CONSENT JUDGMENT AND PERMANENT INJUNCTION FILED IN CIV. NO. 18-651-CFC. Associated Cases: 1:19-cv-00926-CFC, 1:20-cv-00235-CFC, 1:20-cv-00318-CFC, 1:20-cv-01334-CFC, 1:21-cv-00283-CFC(nmf) |
| May 5, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (15 in 1:19-cv-00926-CFC, 19 in 1:19-cv-00560-CFC, 20 in 1:19-cv-00685-CFC) Joint STIPULATION & Proposed Order for Consolidation by Vanda Pharmaceuticals Inc., (20 in 1:20-cv-00235-CFC, 129 in 1:18-cv-00651-CFC, 25 in 1:19-cv-02202-CFC, 133 in 1:18-cv-00690-CFC, 21 in 1:20-cv-00093-CFC, 132 in 1:18-cv-00689-CFC, 20 in 1:20-cv-00083-CFC, 23 in 1:19-cv-02375-CFC, 18 in 1:20-cv-00318-CFC) Stipulation filed by Vanda Pharmaceuticals Inc. Signed by Judge Colm F. Connolly on 5/5/2020. Associated Cases: 1:18-cv-00651-CFC et al.(nmf) |
| Jun 12, 2019 | N/A | Create Case Association (0) Docket Text: Case associated with lead case: Create association to 1:18-cv-00690-CFC. (fms) |
| Jun 12, 2019 | 16 | SO ORDERED (4) Docket Text: SO ORDERED, re (15 in 1:19-cv-00926-CFC, 75 in 1:18-cv-00690-CFC) Stipulation Regarding Consolidation filed by Vanda Pharmaceuticals Inc. C.A. No. 19-926 (CFC) shall be consolidated with C.A. No. 18-690 (CFC) for all purposes. All filings shall be in C.A. No. 18-690 (CFC). Signed by Judge Colm F. Connolly on 6/12/2019. Associated Cases: 1:18-cv-00690-CFC, 1:19-cv-00926-CFC(fms) |
| Jun 10, 2019 | 15 | Stipulation (4) Docket Text: STIPULATION and [Proposed] Order Regarding Consolidation of Cases by Vanda Pharmaceuticals Inc.. (Fahnestock, Derek) |
| Jun 7, 2019 | 13 | Notice of Service (6) Docket Text: NOTICE OF SERVICE of (1) Vanda Pharmaceuticals Inc.'s Identifications of Accused Products, (2) Vanda Pharmaceuticals Inc.'s Disclosures Pursuant to Delaware Default Standard for Discovery Including Discovery of Electronically Stored Information and (3) Plaintiff Vanda Pharmaceuticals Inc.'s Initial Disclosures Pursuant to Fed. R. Civ. P. 26(a)(1) filed by Vanda Pharmaceuticals Inc..(Fahnestock, Derek) |
| Jun 7, 2019 | 14 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1) Defendants MSN Pharmaceuticals Inc. and MSN Laboratories Private Limited's Rule 26(a)(1) Initial Disclosures; and (2) Defendants MSN Pharmaceuticals Inc. and MSN Laboratories Private Limited's Disclosures Under Paragraph 3 of the Default Standard for Discovery filed by MSN Laboratories Private Limited, MSN Pharmaceuticals Inc..(Bilson, David) |
| Jun 6, 2019 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Kira A. Davis, Eric A. Stone, Josephine Young, Daniel J. Klein, Nicholas Groombridge, and Jennifer R. Deneault for Vanda Pharmaceuticals Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:19-cv-00560-CFC, 1:19-cv-00685-CFC, 1:19-cv-00926-CFC(nmg) |
| Jun 4, 2019 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [11] MOTION for Pro Hac Vice Appearance of Attorney Nicholas Groombridge, Eric Alan Stone, Kira A. Davis, Josephine Young, Daniel J. Klein and Jennifer Rea Deneault filed by Vanda Pharmaceuticals Inc. Signed by Judge Colm F. Connolly on 6/4/2019. (fms) |
| Jun 3, 2019 | 11 | Motion for Leave to Appear Pro Hac Vice (9) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Nicholas Groombridge, Eric Alan Stone, Kira A. Davis, Josephine Young, Daniel J. Klein and Jennifer Rea Deneault - filed by Vanda Pharmaceuticals Inc.. (Fahnestock, Derek) |
| Jun 3, 2019 | 12 | SO ORDERED (6) Docket Text: SO ORDERED, re (15 in 1:19-cv-00560-CFC, 10 in 1:19-cv-00926-CFC, 72 in 1:18-cv-00651-CFC, 76 in 1:18-cv-00689-CFC, 73 in 1:18-cv-00690-CFC, 16 in 1:19-cv-00685-CFC) Joint STIPULATION regarding Case Schedule and Claim Construction for U.S. Patent No. 10,149,829. Signed by Judge Colm F. Connolly on 6/3/2019. Associated Cases: 1:18-cv-00651-CFC et al.(nmf) |
| May 31, 2019 | 10 | Stipulation (6) Docket Text: Joint STIPULATION regarding Case Schedule and Claim Construction for U.S. Patent No. 10,149,829 by Vanda Pharmaceuticals Inc.. (Fahnestock, Derek) |
| May 28, 2019 | 8 | Answer to Complaint (20) Docket Text: ANSWER to [1] Complaint, Affirmative Defenses, COUNTERCLAIM against Vanda Pharmaceuticals Inc. by MSN Pharmaceuticals Inc., MSN Laboratories Private Limited.(Phillips, John) |
| May 28, 2019 | 9 | Disclosure Statement (1) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent MSN Laboratories Private Limited for MSN Pharmaceuticals Inc. filed by MSN Laboratories Private Limited, MSN Pharmaceuticals Inc.. (Bilson, David) |
| May 22, 2019 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Colm F. Connolly. Please include the initials of the Judge (CFC) after the case number on all documents filed. (nmg) |
| May 21, 2019 | 6 | Summons Returned Executed (2) Docket Text: SUMMONS Returned Executed by Vanda Pharmaceuticals Inc.. MSN Pharmaceuticals Inc. served on 5/21/2019, answer due 6/11/2019. (Fahnestock, Derek) |
| May 21, 2019 | 7 | Summons Returned Executed (2) Docket Text: SUMMONS Returned Executed by Vanda Pharmaceuticals Inc.. MSN Laboratories Private Limited served on 5/21/2019, answer due 6/11/2019. (Fahnestock, Derek) |
| May 20, 2019 | N/A | Summons Issued (0) Docket Text: Summons Issued with Magistrate Consent Notice attached as to MSN Laboratories Private Limited on 5/20/2019; MSN Pharmaceuticals Inc. on 5/20/2019. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (ceg) |
| May 17, 2019 | 1 | Main Document (13) Docket Text: COMPLAINT FOR PATENT INFRINGEMENT filed against MSN Laboratories Private Limited, MSN Pharmaceuticals Inc. - Magistrate Consent Notice to Pltf. (Filing fee $ 400, receipt number 0311-2645782.) - filed by Vanda Pharmaceuticals Inc. (Attachments: # (1) Exhibit A, # (2) Civil Cover Sheet)(ceg) |
| May 17, 2019 | 1 | Exhibit A (36) |
| May 17, 2019 | 1 | Civil Cover Sheet (1) |
| May 17, 2019 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (ceg) |
| May 17, 2019 | 3 | ANDA Form (1) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 5/14/2019. Date of Expiration of Patent: 1/25/2033.Thirty Month Stay Deadline: 7/31/2021. (ceg) |
| May 17, 2019 | 4 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 10,149,829 B2. (ceg) |
| May 17, 2019 | 5 | Disclosure Statement (1) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Other Affiliate BlackRock, Inc. for Vanda Pharmaceuticals Inc. filed by Vanda Pharmaceuticals Inc. (ceg) |
| May 17, 2019 | 1 | Complaint* (1) |
